Dr Jitendra Singh unveils Omicron specific mRNA based Booster vaccine "GEMCOVAC -OM" Ruchika Sharma26 Jun 2023 12:30 PM ISTGEMCOVAC -OM is a thermostable vaccine and does not require ultra-cold chain infrastructure used for other approved mRNA- based vaccines.
DCGI nod to India's first mRNA based Omicron-specific booster vaccine Ruchika Sharma21 Jun 2023 11:37 AM ISTGEMCOVAC-OM is delivered intradermally using a needle-free device called Tropis, developed by PharmaJet, USA.
USFDA authorizes second Omicron-updated COVID booster for older adults Ruchika Sharma20 April 2023 4:30 PM ISTUS: The U.S. Food and Drug Administration on Tuesday authorized a second dose of Omicron-targeting COVID-19 vaccines for older adults as well as those...
436 cases of XBB1.16.1 mutated sub-variant found in India: INSACOG Roshni Dhar18 April 2023 5:44 PM ISTAmid rising Covid cases in India, 436 cases of XBB1.16.1 mutated sub-variant have been detected in the country till now, revealed Indian SARS-CoV-2...
Health Bulletin 18/April/2023 Roshni Dhar18 April 2023 4:20 PM ISTHere are the top health news for the day:436 cases of XBB1.16.1 mutated sub-variant found in India: INSACOGAccording to Indian SARS-CoV-2 Genomics...
XBB.1.16, new Arcturus variant Dr. Nandita Mohan17 April 2023 5:01 PM ISTThe Omicron subvariant, XBB.1.16 also known as Arcturus is fueling the latest hike of cases in India, US, Singapore, Australia, and other countries....
Medical Bulletin 10/April/2023 Isra Zaman10 April 2023 4:18 PM ISTHere are the top medical news for the day:Simple blood test can accurately predict neuroendocrine tumor response to radiopharmaceutical therapyWhile...
Study suggests omicron to appear more deadly than seasonal influenza Isra Zaman10 April 2023 9:15 AM ISTInfluenza and COVID-19 are both respiratory diseases with similar modes of transmission. In December 2021, influenza re-emerged in Israel after it...
SARS-CoV-2 Omicron Breakthrough Infectios in Patients with Multiple Sclerosis Dr. Krishna Shah24 March 2023 10:00 AM ISTSARS-COV-2 omicron breakthrough infections are more prevalent in patients with MS on anti-CD20 therapies and S1PR modulators compared with other...
Pfizer, BioNTech submit application to USFDA for emergency use nod of Omicron BA.4/BA.5-adapted bivalent COVID booster in children under 5 years Ruchika Sharma2 March 2023 4:15 PM ISTNew York: Pfizer Inc. and BioNTech SE have submitted an application to the U.S. Food and Drug Administration (FDA) for Emergency Use...
Pfizer, BioNTech seek USFDA nod for Omicron BA.4/BA.5-Adapted Bivalent COVID vaccine for ages 12 years and older as primary series or booster Ruchika Sharma25 Feb 2023 12:30 PM ISTNew York: Pfizer Inc. and BioNTech SE have announced that they have submitted a supplemental Biologics License Application (sBLA) to the U.S....
China needs good COVID booster vaccine like Covovax, but they haven't given positive response: Serum Institute CEO Adar Poonawalla Ruchika Sharma29 Jan 2023 12:45 PM ISTAs per sources, NTAGI is likely to soon meet regarding the inclusion of COVID vaccine Covovax on the CoWIN portal as heterologous booster dose for...
